Somalia PR Observer

Latest Breaking News and Updates

Eli Lilly and Company

Health Maintenance

Boehringer Ingelheim and Lilly Revising Operational Structure of Diabetes Alliance in Certain Countries

– Significant portion of alliance opportunity will remain unchanged; some countries will transition to exclusive promotion in 2015 INDIANAPOLIS and INGELHEIM, Germany, Oct. 29, 2014 / PRNewswire / Asianet-Pakistan — In a move that will strengthen their alliance by enhancing efficiencies and enabling greater focus on product launches, Boehringer Ingelheim and Eli Lilly and Company […]

Health Maintenance

Lilly Releases Report on Corporate Responsibility Efforts

– Company communicates progress on numerous indicators of economic, environmental, and social performance INDIANAPOLIS, Dec. 5, 2013 / PRNewswire / Asianet-Pakistan – Eli Lilly and Company (NYSE: LLY) has released its 2012-13 Corporate Responsibility Report. The report offers a comprehensive look at the company’s progress on numerous corporate responsibility goals and efforts, including: Charitable contributions Lilly’s […]

General

Data Presented at 49th EASD Annual Meeting Show Treatment with Lilly’s Investigational Dulaglutide Resulted in Improved Patient-Reported Health Outcomes

– Improvements in several indicators of diabetes management, including perceptions about hyperglycaemia and weight, observed for investigational GLP-1 receptor agonist BARCELONA, Spain, Sept. 26, 2013 /PRNewswire / Asianet-Pakistan – Eli Lilly and Company (NYSE: LLY) today announced positive patient-reported health outcomes from a Phase III clinical trial of dulaglutide, an investigational, long-acting glucagon-like peptide 1 (GLP-1) receptor […]